產(chǎn)品詳情
所在位置: 首頁> 產(chǎn)品目錄> 試劑>

  • 產(chǎn)品名稱：Linagliptin

  • 產(chǎn)品型號：
  • 產(chǎn)品廠商：TargetMol
  • 產(chǎn)品文檔：
你添加了1件商品 查看購物車
簡單介紹：
Linagliptin
詳情介紹：
Purpose Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes . Two pharmacological characteristics that sets linagliptin apart from other DPP-4 inhibitors is that it has a non-linear pharmacokinetic profile and is not primarily eliminated by the renal system. FDA approved on May 2, 2011.
Characteristics Tradename: TRADJENTA
Source of Compound: synthetic, BI-1356
Target: DPP-4 inhibitor
Receptor: DPP-4
Status: USAN, INN
Purification All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
Purity 98?%
Formula C25H28N8O2
Solubility DMSO 17 mg/mL,Ethanol 1 mg/mL
Molecular Weight 472.54 g/mol
CAS-No 668270-12-0
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Solid
Storage -20 °C
Storage Comment For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.
Expiry Date 24 months